New patent expiration for Bristol-myers Squibb drug EVOTAZ

Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are three patents…

The post New patent expiration for Bristol-myers Squibb drug EVOTAZ appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: